Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: A historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Wang, Ting Yu ^a   Eguale, Tewodros ^a   Tamblyn, Robyn ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Guidelines adherence; Medical informatics; Metformin; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

AGED; ARTICLE; CANADA; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; HEALTH PERSONNEL ATTITUDE; HUMAN; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; STATISTICS;

AGED; ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; GUIDELINE ADHERENCE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUEBEC;

EID: 84886189845     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-442     Document Type: Article

References (38)

1. Prevalence and cost of diabetes. http://www.diabetes.ca/diabetes-and-you/ what/facts/
2. Morbidity and mortality in iabetics in the Framingham population. Sixteen year follow-up study. Garcia MJ, McNamara PM, Gordon T, Kannel W, Diabetes 1974 23 2 105
3. Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Lee E, Keen H, Bennett P, Fuller J, Lu M, Diabetologia 2001 44 3 13
4. The quality of health care delivered to adults in the United States. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA, N Engl J Med 2003 348 26 2635 2645 (Pubitemid 36741592)
5. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Harris SB, Ekoe JM, Zdanowicz Y, Webster-Bogaert S, Diabetes Res Clin Pract 2005 70 1 90 97 (Pubitemid 41207652)
6. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO, Diabetes Care 2004 27 1 17 20 (Pubitemid 38196703)
7. Adherence to clinical guidelines in management of diabetes and prevention of cardiovascular disease in Qatar. Diab MI, Johnson BJ, Hudson S, Int J Clinical Pharmacy 2013 35 1 101 112
8. A patient-based study on the adherence of physicians to guidelines for the management of type 2 diabetes in Turkey. Satman I, Imamoglu S, Yilmaz C, Diabetes Res Clin Pract 2012 98 1 75 82
9. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes. Rettig SHJ, J Am Pharm Assoc 2011 51 2 220
10. Canadian Diabetes Association 2008 Clinical Practice Guidelines. http://www.diabetes.ca/files/cpg2008/cpg-2008.pdf
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Group UPDSU, Lancet 1998 352 9131 854 865
12. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Diabetes Association. Committee CDACPGE, Can J Diabetes 2003 27 Suppl 2 10 13
13. Jaakkimainen L, Klein-Geltink J, Guttmann A, Barnsley J, Zagorski B, Kopp A, Indicators of primary care based on administrative data Primary Care in Ontario Toronto Canada: Institute for Clinical Evaluative Sciences 2006
14. Prescription drug insurance. http://www.ramq.gouv.qc.ca/en/citizens/ prescription-drug-insurance/Pages/eligibility.aspx
15. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. Tamblyn R, Lavoie G, Petrella L, Monette J, J Clin Epidemiol 1995 48 8 999 1009
16. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, McLeod P, Laprise R, Can Med Assoc J 2003 169 6 549 556 (Pubitemid 37174595)
17. Enhancing pharmacosurveillance with systematic collection of treatment indication in electronic prescribing: a validation study in Canada. Eguale T, Winslade N, Hanley JA, Buckeridge DL, Tamblyn R, Drug Saf 2010 33 7 559 567
18. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. Tamblyn R, Huang A, Kawasumi Y, Bartlett G, Grad R, Jacques A, Dawes M, Abrahamowicz M, Perreault R, Taylor L, et al. J Am Med Inform Assoc 2006 13 2 148 159 (Pubitemid 43332905)
19. Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary CareOff-label Prescribing in Primary Care. Eguale T, Buckeridge DL, Winslade NE, Benedetti A, Hanley JA, Tamblyn R, Arch Intern Med 2012 172 10 781 788
20. Validating an instrument for selecting interventions to change physician practice patterns: a Michigan Consortium for Family Practice Research study. Green LA, Gorenflo DW, Wyszewianski L, J Fam Pract 2002 51 11 938 942 (Pubitemid 35291615)
21. An observational study of the effectiveness of practice guideline implementation strategies examined according to physicians' cognitive styles. Green LA, Wyszewianski L, Lowery JC, Kowalski CP, Krein SL, Implementation science: IS 2007 2 41
22. Physician and practice characteristics associated with the early utilization of new prescription drugs. Tamblyn R, Mcleod P, Hanley JA, Girard N, Hurley J, Med Care 2003 41 8 895 908
23. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. Nissen SE, Wolski K, N Engl J Med 2007 356 24 2457 2471 (Pubitemid 46919772)
24. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone. Dahabreh IJ, Economopoulos K, Clin Trials 2008 5 2 116 120 (Pubitemid 351682521)
25. New use of rosiglitazone decreased following publication of a metaanalysis suggesting harm. Shah B, Juurlink D, Austin P, Mamdani M, Diabet Med 2008 25 7 871 874
26. From best evidence to best practice: effective implementation of change in patients' care. Grol R, Grimshaw J, Lancet 2003 362 9391 1225 1230 (Pubitemid 37255352)
27. Developing and implementing clinical practice guidelines. Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz B, Watt I, Long A, Sheldon T, Quality in Health care 1995 4 1 55
28. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Grimshaw JM, Russell IT, The Lancet 1993 342 8883 1317 1322 (Pubitemid 23345178)
29. Effectiveness and efficiency of guideline dissemination and implementation strategies. Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L, Whitty P, Eccles M, Matowe L, Shirran L, Int J Technol Assess Health Care 2005 21 01 149-149
30. The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M, Family practice 2002 19 4 344 349 (Pubitemid 34846832)
31. Diabetes care in general practice: an approach to audit of process and outcome. Tunbridge F, Millar JP, Schofield PJ, Spencer JA, Young G, Home P, Br J Gen Pract 1993 43 372 291
32. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Davis DA, Taylor-Vaisey A, Can Med Assoc J 1997 157 4 408 416 (Pubitemid 27384745)
33. Diabetes guidelines: easier to preach than to practise. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV, Med J Aust 2006 185 6 305 309
34. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, N Engl J Med 2002 346 6 393 403 (Pubitemid 34437694)
35. Contraindications to the use of metformin: evidence suggests that it is time to amend the list. Jones G, Macklin J, Alexander W, Br Med J 2003 326 7379 4
36. Metformin's contraindications should be contraindicated. McCormack J, Johns K, Tildesley H, Can Med Assoc J 2005 173 5 502 504 (Pubitemid 41225045)
37. Metformin: a new oral biguanide. Campbell RK, White JR Jr, Saulie BA, Clin Ther 1996 18 3 360 371 discussion 359 (Pubitemid 26248896)
38. Do guidelines influence medical practice? Changes in management of acute pancreatitis 7 years after the publication of the French guidelines. Rebours V, Levy P, Bretagne JF, Bommelaer G, Hammel P, Ruszniewski P, Eur J Gastroenterol Hepatol 2012 24 2 143 148